Neurocrine Biosciences (NBIX) Q4 Earnings and Revenues Lag Estimates
Portfolio Pulse from
Neurocrine Biosciences (NBIX) reported Q4 earnings of $1 per share, missing the Zacks Consensus Estimate of $1.56. This is a decrease from $1.44 per share a year ago.
February 06, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neurocrine Biosciences reported Q4 earnings of $1 per share, missing estimates and showing a decline from last year's $1.44 per share.
The earnings miss and year-over-year decline in EPS are likely to negatively impact investor sentiment, potentially leading to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100